☆ 4.7 Article

Response kinetics of different classes of antibodies to SARS-CoV2 infection in the Japanese population: The IgA and IgG titers increased earlier than the IgM titers

INTERNATIONAL IMMUNOPHARMACOLOGY (2022)

Related references

Note: Only part of the references are listed.

Article Medicine, General & Internal

Dynamics and Correlation Among Viral Positivity, Seroconversion, and Disease Severity in COVID-19 A Retrospective Study

Yu Fu et al.

Summary: The study found that among patients with laboratory-confirmed COVID-19, the viral PCR positivity rate peaked within the first 3 days, while the seroconversion rate peaked within 4 to 5 weeks. Critically ill patients had a longer duration of viral positivity, and low IgM titers were identified as an independent risk factor for persistent viral positivity.

ANNALS OF INTERNAL MEDICINE (2021)

Add to Collection

Article Infectious Diseases

Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19

Satoshi Kutsuna et al.

Summary: The study found that male sex, high C-reactive protein levels during the acute phase, and diabetes mellitus were associated with elevated antibody titers in convalescent COVID-19 patients. Antibody titers tended to peak in the first 5 or 6 weeks after symptom onset.

JOURNAL OF INFECTION AND CHEMOTHERAPY (2021)

Add to Collection

Article Microbiology

Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays

Georg Semmler et al.

Summary: This study found that differences in sensitivity among commercial immunoassays during acute SARS-CoV-2 infection are only partly related to the target antigen. NCP-specific IgA and IgG antibodies are detected earlier, while higher levels of S1-specific IgA antibodies occur in severely ill patients.

JOURNAL OF CLINICAL MICROBIOLOGY (2021)

Add to Collection

Article Virology

Antibody response patterns in COVID-19 patients with different levels of disease severity in Japan

Kazuo Imai et al.

Summary: The study analyzed antibody response patterns of COVID-19 patients in Japan according to disease severity. Results showed that patients with severe and critical cases had stronger antibody responses 11 days after symptom onset, while mild cases had lower seroconversion rates of antibodies against N and S1.

JOURNAL OF MEDICAL VIROLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan

Rin Yokoyama et al.

Summary: The study validated the usefulness of measuring serum antibodies against SARS-CoV-2 using the iFlash3000 CLIA analyzer, demonstrating that the measurement system successfully detects SARS-CoV-2 IgM/IgG with good repeatability and precision. The new automated method for detecting antibodies against N and S proteins of SARS-CoV-2 shows sufficient performance for laboratory testing, with concordance rates of 98.1% for SARS-CoV-2 IgM and 100% for IgG among PCR-negative cases.

PLOS ONE (2021)

Add to Collection

Article Multidisciplinary Sciences

Time course of the sensitivity and specificity of anti-SARS-CoV-2 IgM and IgG antibodies for symptomatic COVID-19 in Japan

Yuki Nakano et al.

Summary: This study focused on investigating the time courses of SARS-CoV-2 IgM and IgG titers in patients in Japan, finding that the sensitivity of antibody tests varied significantly at different time points after symptom onset, with increased accuracy as the days since onset increased.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Medical Laboratory Technology

Combination of a SARS-CoV-2 IgG Assay and RT-PCR for Improved COVID-19 Diagnosis

Kotaro Aoki et al.

Summary: The study evaluated the performance of the combination of RT-PCR and IgG assay for diagnosing COVID-19. Results showed that sensitivity increased with the number of days after symptom onset, while specificity remained high across different case groups.

ANNALS OF LABORATORY MEDICINE (2021)

Add to Collection

Article Immunology

Comparative Analysis of Antigen-Specific Anti-SARS-CoV-2 Antibody Isotypes in COVID-19 Patients

Hidetsugu Fujigaki et al.

Summary: This study investigated the kinetics and neutralizing activity of various Ag-specific Ab isotypes against SARS-CoV-2 in serum of COVID-19 patients, with IgG against RBD showing the best correlation with virus-neutralizing activity. The results provide valuable information for the selection of serological tests for seroprevalence and vaccine evaluation studies.

JOURNAL OF IMMUNOLOGY (2021)

Add to Collection

Article Microbiology

Clinical characteristics and antibody response to SARS-CoV-2 spike 1 protein using VITROS Anti-SARS-CoV-2 antibody tests in COVID-19 patients in Japan

Mayu Nagura-Ikeda et al.

Summary: Serological tests for COVID-19 play an important role in surveillance and diagnosis. This study aimed to evaluate the clinical utility of VITROS SARS-CoV-2 antibody tests in patients with different severity of COVID-19 in Japan. The intensity of total and IgG antibodies was significantly higher in severe cases compared to mild cases, especially after 11 days of symptom onset.

JOURNAL OF MEDICAL MICROBIOLOGY (2021)

Add to Collection

Article Virology

Longitudinal detection of SARS-CoV-2-specific antibody responses with different serological methods

Petra Emmerich et al.

Summary: Serological testing for anti-SARS-CoV-2 antibodies was conducted using 129 serum samples from patients with confirmed COVID-19 and healthy donors, with different assays showing varying sensitivities and specificities. IgA and IgM assays had higher sensitivities, peaking between 11 and 20 days post symptom onset, while IgG assays peaked between 20 and 60 days. The use of IIFT with the whole SARS-CoV-2 substrate showed the highest sensitivities in detecting prior infections.

JOURNAL OF MEDICAL VIROLOGY (2021)

Add to Collection

Article Cell Biology

Serological analysis reveals an imbalanced IgG subclass composition associated with COVID-19 disease severity

Jennifer L. Yates et al.

Summary: The severity of COVID-19 is associated with elevated levels of SARS-CoV-2-specific antibodies in severe cases, with spike-specific IgG subclass utilization potentially contributing to disease severity through potent Fc-mediated effector functions. These findings may have significant implications for SARS-CoV-2 vaccine design and convalescent plasma therapy.

CELL REPORTS MEDICINE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Dynamics of neutralizing antibody responses to SARS-CoV-2 in patients with COVID-19: an observational study

Xin Xu et al.

Summary: According to a study in Hubei, China, the dynamics of neutralizing antibody (NAbs) response to SARS-CoV-2 in COVID-19 patients showed that NAbs seroconversion occurred at around 5.5 days post onset, with a positivity rate of 52% within the first week, reaching 100% by the third week, and maintaining above 97% for up to 6 months. NAbs peaked in the fourth week and were positively associated with disease severity and age, while inversely associated with serum albumin levels. The half-life of NAbs was 61 days within the first two months, which then slowed to 104 days afterward.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Add to Collection

Article Immunology

Comprehensive analysis of SARS-CoV-2 antibody dynamics in New Zealand

Alana L. Whitcombe et al.

Summary: This study found that antibodies to SARS-CoV-2 can persist for up to 8 months following mild-to-moderate infection, with RBD and S protein IgG, as well as NAbs, being relatively stable over time. The robust antibody response observed may be attributed to the initial exposure without immune boosting due to lack of community transmission in New Zealand.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2021)

Add to Collection

Article Microbiology

A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2

Alba Grifoni et al.

CELL HOST & MICROBE (2020)

Add to Collection

Article Virology

Serologic Response to SARS-CoV-2 in COVID-19 Patients with Different Severity

Wen-Hua Kong et al.

VIROLOGICA SINICA (2020)

Add to Collection

Article Medical Laboratory Technology

Development and multicenter performance evaluation of fully automated SARS-CoV-2 IgM and IgG immunoassays

Chungen Qian et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)

Add to Collection

Article Medicine, Research & Experimental

Kinetics of viral load and antibody response in relation to COVID-19 severity

Yanqun Wang et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Add to Collection

Review Multidisciplinary Sciences

A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity

Angkana T. Huang et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Article Immunology

Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome

Katharina Roltgen et al.

SCIENCE IMMUNOLOGY (2020)

Add to Collection

Article Biology

The kinetics of humoral response and its relationship with the disease severity in COVID-19

Lili Ren et al.

COMMUNICATIONS BIOLOGY (2020)

Add to Collection

Article Medicine, Research & Experimental

Apparent di ff erence in fatalities between Central Europe and East Asia due to SARS-COV-2 and COVID-19: Four hypotheses for possible explanation

Naoki Yamamoto et al.

MEDICAL HYPOTHESES (2020)

Add to Collection

Article Multidisciplinary Sciences

Preexisting and de novo humoral immunity to SARS-CoV-2 in humans

Kevin W. Ng et al.

SCIENCE (2020)

Add to Collection

Article Immunology

Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients

Baoqing Sun et al.

EMERGING MICROBES & INFECTIONS (2020)

Add to Collection

Article Immunology

T Cell-Independent IgA Class Switch Recombination Is Restricted to the GALT and Occurs Prior to Manifest Germinal Center Formation

Peter Bergqvist et al.

JOURNAL OF IMMUNOLOGY (2010)

Add to Collection

Article Immunology

Prior Immunization with Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-CoV) Nucleocapsid Protein Causes Severe Pneumonia in Mice Infected with SARS-CoV

Fumihiko Yasui et al.

JOURNAL OF IMMUNOLOGY (2008)

Add to Collection

Article Immunology

Gut IgA class switch recombination in the absence of CD40 does not occur in the lamina propria and is independent of germinal centers

Peter Bergqvist et al.

JOURNAL OF IMMUNOLOGY (2006)

Add to Collection

Article Medicine, General & Internal

Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants

Damon Deming et al.

PLOS MEDICINE (2006)

Add to Collection

Article Multidisciplinary Sciences

Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice

H Bisht et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Add to Collection

Article Immunology

Activation of autoreactive B cells by CpG dsDNA

GA Viglianti et al.

IMMUNITY (2003)

Add to Collection

Article Multidisciplinary Sciences

Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

EA Leadbetter et al.

NATURE (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.